Microsampling Approach for Monitoring of Kinase Inhibitor Targeted Therapies

NCT05598788 · clinicaltrials.gov ↗

UNKNOWN

Status

360

Enrollment

OTHER

Sponsor class

Conditions

Blood Concentrations of Nine Anti-cancer Drugs : Axitinib, Olaparib, regorafénib, Cabozantinib, Niraparib, Talazoparib, Palbociclib, Abemaciclib, Tucatinib

Interventions

OTHER: Measurement of drug concentrations

Sponsor

Rennes University Hospital